N/A N=10 Postoperative Telehealth Mindfulness Intervention After Spine Surgery
Chronic Low-back Pain · Postsurgical Pain · Opioid Use
Primary: Feasibility - Study Retention — 3 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 1 N=28 A Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic Hypersomnia
Idiopathic Hypersomnia
Primary: Percentage of Participants Who Experienced at Least One Treatment-emergent Adverse Event (TEAE) — 14.8; 40.0 percentage of participants
Phase 2 N=57 Enzalutamide With or Without Vaccine Therapy for Advanced Prostate Cancer
Prostate Cancer
Primary: Time to Progression (TTP) — 24.2; 19.1 Months
Phase 2 N=9 Glenohumeral Cortisone Injection
Humeral Fractures
Primary: American Shoulder Elbow Society Score — 46; 87 score on a scale
N/A N=27 Multi-Wavelength Laser Tattoo Removal Pivotal Study
Tattoo Removal
Primary: Tattoo Clearing as Rated by Blinded Evaluator — 21 Participants
Phase 2 N=33 Study of Exchange of Travoprost Intraocular Implant
Open Angle Glaucoma
Primary: Ocular Safety — 13 subjects
Phase 4 N=63 Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients
Cancer
Primary: Sniff Nasal Inspiratory Pressure (SNIP) — 90; 87; 89; 109 cmH20
Phase 2 N=10 Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence
Alcohol Dependence
Primary: Change in Percent Heavy Drinking Days — -25.962 percentage of days — p=0.008
Phase 2 N=30 Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa
Retinitis Pigmentosa
Primary: Safety of Intravitreal Injection of hRPC — 15; 6; 6; 2 Participants
N/A N=22 Peer Support for Exercise in Older Veterans With Psychotic Disorders
Psychotic Disorder
Primary: Intervention Engagement — 8 Participants
N/A N=100 Efficacy of the Nanodropper Device on Pupillary Dilation
Dilation
Primary: Spherical Equivalent — -2.62; -2.28; -0.86; -0.55 Diopters — p=0.22
N/A N=83 Dietary Acid Load, Kidney Function and Disability in Elderly
Chronic Kidney Disease · Disability
Primary: Blood Bicarbonate — 22.8; 23.2 mmol/L
N/A N=60 Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90mcg Per Actuation in Healthy Volunteers Under Fasting Conditions
Healthy
Primary: Cmax — 996.998; 979.630 pg/mL — p=<0.0001
Phase 3 N=375 An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
Dravet Syndrome
Primary: Percentage of Participants With Treatment-emergent Adverse Events (TEAEs) During the Open-label Extension (OLE) Treatment Period — 98.1 percentage of participants
N/A N=53 Mobilizing Evidence Into Action to Improve Outcomes of Vulnerable Seniors
Hip Fractures · Femoral Fractures
Primary: Short Physical Performance Battery — 8.24; 9.08 score on a scale